Published in Proc Natl Acad Sci U S A on September 25, 2008
Functional anatomy of T cell activation and synapse formation. Annu Rev Immunol (2010) 3.01
Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol (2013) 2.19
Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J Virol (2009) 1.43
The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol (2009) 1.15
Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci U S A (2008) 1.08
Protective and dysregulated T cell immunity in RSV infection. Curr Opin Virol (2013) 1.08
The inability to disrupt the immunological synapse between infected human T cells and APCs distinguishes HIV-1 from most other primate lentiviruses. J Clin Invest (2009) 1.07
Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs. Am J Physiol Lung Cell Mol Physiol (2010) 0.95
Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection. Respir Res (2010) 0.87
Influence of dendritic cells on viral pathogenicity. PLoS Pathog (2009) 0.87
The role of Th17 and Treg responses in the pathogenesis of RSV infection. Pediatr Res (2015) 0.86
Impaired learning resulting from respiratory syncytial virus infection. Proc Natl Acad Sci U S A (2013) 0.86
Respiratory syncytial virus infection modifies and accelerates pulmonary disease via DC activation and migration. J Leukoc Biol (2013) 0.84
Therapeutic targeting of respiratory syncytial virus G-protein. Immunotherapy (2010) 0.84
Salmonella pathogenicity island 1 differentially modulates bacterial entry to dendritic and non-phagocytic cells. Immunology (2010) 0.83
IL-27R-mediated regulation of IL-17 controls the development of respiratory syncytial virus-associated pathogenesis. Am J Pathol (2014) 0.83
Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection. Future Virol (2011) 0.81
Respiratory syncytial virus (RSV) infection in elderly mice results in altered antiviral gene expression and enhanced pathology. PLoS One (2014) 0.79
Development of Acquired Immunity following Repeated Respiratory Syncytial Virus Infections in Cotton Rats. PLoS One (2016) 0.79
Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc Natl Acad Sci U S A (2014) 0.79
Live attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responses. PLoS One (2014) 0.79
Modulation of host adaptive immunity by hRSV proteins. Virulence (2014) 0.78
Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity. Paediatr Respir Rev (2015) 0.78
The cytoskeletal scaffold Shank3 is recruited to pathogen-induced actin rearrangements. Exp Cell Res (2009) 0.78
Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells. Immunology (2015) 0.77
Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells. Immunology (2013) 0.77
The infectious march: the complex interaction between microbes and the immune system in asthma. Immunol Allergy Clin North Am (2010) 0.77
Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design. Immunology (2014) 0.77
Acute Viral Respiratory Infection Rapidly Induces a CD8+ T Cell Exhaustion-like Phenotype. J Immunol (2015) 0.77
Dendritic cells in human Pneumovirus and Metapneumovirus infections. Viruses (2013) 0.76
Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse. Clin Dev Immunol (2013) 0.76
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus. Yonsei Med J (2016) 0.75
Modulation of Host Immunity by the Human Metapneumovirus. Clin Microbiol Rev (2016) 0.75
Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design. Int J Mol Sci (2017) 0.75
Neonatal respiratory syncytial virus infection has an effect on lung inflammation and the CD4(+) CD25(+) T cell subpopulation during ovalbumin sensitization in adult mice. Clin Exp Immunol (2016) 0.75
A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus. Hum Vaccin Immunother (2017) 0.75
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease. J Virol (2017) 0.75
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses. Nat Microbiol (2017) 0.75
Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection. Virulence (2016) 0.75
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA (1999) 8.07
Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child (1986) 7.39
Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med (1979) 5.44
Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis (1991) 3.27
Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol (2003) 3.03
Cell biology of cytotoxic and helper T cell functions: immunofluorescence microscopic studies of single cells and cell couples. Annu Rev Immunol (1989) 2.83
DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J Immunol (2000) 2.50
Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med (2006) 2.14
Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med (2002) 2.12
Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity (2006) 1.90
Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol (2005) 1.87
Immunological synapses are versatile structures enabling selective T cell polarization. Immunity (2005) 1.65
In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain. J Exp Med (2006) 1.52
Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J Allergy Clin Immunol (2004) 1.50
Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J Immunol (2006) 1.40
Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells. J Immunol (2004) 1.33
Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J Immunol (2005) 1.30
Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells. Immunology (2003) 1.30
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol (2006) 1.28
Characterization of CD4+ memory T cell responses directed against common respiratory pathogens in peripheral blood and lung. J Infect Dis (2007) 1.27
CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J Immunol (2007) 1.26
Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J Virol (2005) 1.25
Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells. Clin Exp Immunol (2002) 1.25
Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses. Cancer Res (2003) 1.24
Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J Virol (2003) 1.23
Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells. Infect Immun (2006) 1.21
Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections. Eur J Immunol (2006) 1.20
Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact. J Virol (2002) 1.19
Following antigen challenge, T cells up-regulate cell surface expression of CD4 in vitro and in vivo. J Immunol (1998) 1.10
Inhibition of T cell receptor signal transduction by tyrosine kinase-interacting protein of Herpesvirus saimiri. J Exp Med (2004) 1.03
Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes. J Gen Virol (2004) 1.02
HIV-1 Nef employs two distinct mechanisms to modulate Lck subcellular localization and TCR induced actin remodeling. PLoS One (2007) 1.02
CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. J Immunol (2006) 1.01
Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-beta-dependent mechanism. Proc Natl Acad Sci U S A (2008) 1.00
Modulation of T cell function by TCR/pMHC binding kinetics. Immunobiology (2006) 1.00
The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific. Immunology (2008) 0.95
Measles virus contact with T cells impedes cytoskeletal remodeling associated with spreading, polarization, and CD3 clustering. Traffic (2006) 0.94
Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus. J Gen Virol (1991) 0.93
Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells. Immunology (2007) 0.86
Role of serum neutralizing antibody in reinfection of respiratory syncytial virus. Pediatr Int (2004) 0.86
Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus. Clin Exp Immunol (2007) 0.85
Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies. Cell Immunol (2007) 0.85
Modulation of immunological synapse by membrane-bound and soluble ligands. Cytokine Growth Factor Rev (2007) 0.85
Identification and characterization of the antigen-specific subpopulation of alloreactive CD4+ T cells in vitro and in vivo. Transplantation (2000) 0.84
Regulation of mite allergen-pulsed murine dendritic cells by respiratory syncytial virus. Am J Respir Crit Care Med (2003) 0.81
Enhanced cytokine production by milk macrophages following infection with respiratory syncytial virus. J Leukoc Biol (1997) 0.80
Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2. Vaccine (2007) 0.79
Detection of human respiratory syncytial virus genotype specific antibody responses in infants. J Med Virol (2004) 0.78
Activated TCRs remain marked for internalization after dissociation from pMHC. Nat Immunol (2002) 3.01
T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc Natl Acad Sci U S A (2005) 1.49
Gestational hypothyroidism increases the severity of experimental autoimmune encephalomyelitis in adult offspring. Thyroid (2013) 1.41
Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells. J Immunol (2004) 1.33
Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J Immunol (2009) 1.22
Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells. Infect Immun (2006) 1.21
Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes. Hypertension (2014) 1.19
T cell immunity evasion by virulent Salmonella enterica. Immunol Lett (2007) 1.19
The Salmonella enterica sv. Typhimurium smvA, yddG and ompD (porin) genes are required for the efficient efflux of methyl viologen. Mol Microbiol (2002) 1.19
Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J Pharmacol Exp Ther (2004) 1.10
Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci U S A (2008) 1.08
Role of dopamine in the physiology of T-cells and dendritic cells. J Neuroimmunol (2009) 1.06
Aldosterone as a modulator of immunity: implications in the organ damage. J Hypertens (2011) 1.05
B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy. Arthritis Res Ther (2010) 1.04
Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther (2006) 1.01
Host immunity during RSV pathogenesis. Int Immunopharmacol (2008) 1.01
Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus. Immunology (2008) 1.01
Modulation of T cell function by TCR/pMHC binding kinetics. Immunobiology (2006) 1.00
The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge. Immunology (2007) 0.98
Functional gap junctions accumulate at the immunological synapse and contribute to T cell activation. J Immunol (2011) 0.97
Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection. J Immunol (2010) 0.96
The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific. Immunology (2008) 0.95
Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells. Proc Natl Acad Sci U S A (2013) 0.94
Immune complex-induced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells. Proc Natl Acad Sci U S A (2007) 0.94
Research priorities for neglected infectious diseases in Latin America and the Caribbean region. PLoS Negl Trop Dis (2010) 0.94
Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response. Microbes Infect (2012) 0.92
Mechanisms used by virulent Salmonella to impair dendritic cell function and evade adaptive immunity. Immunology (2012) 0.92
Interplay between thermal and immune ecology: effect of environmental temperature on insect immune response and energetic costs after an immune challenge. J Insect Physiol (2011) 0.90
The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity. Eur J Immunol (2009) 0.90
Local cytokine response upon respiratory syncytial virus infection. Immunol Lett (2010) 0.89
Excision of an unstable pathogenicity island in Salmonella enterica serovar Enteritidis is induced during infection of phagocytic cells. PLoS One (2011) 0.89
Gap junctions at the dendritic cell-T cell interface are key elements for antigen-dependent T cell activation. J Immunol (2009) 0.89
Respiratory syncytial virus infection and immunity. Rev Med Virol (2012) 0.88
Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy. Invest Ophthalmol Vis Sci (2007) 0.88
Molecular interactions between dendritic cells and Salmonella: escape from adaptive immunity and implications on pathogenesis. Crit Rev Immunol (2005) 0.88
Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis. Curr Med Chem (2009) 0.87
Modulation of the dendritic cell-T-cell synapse to promote pathogen immunity and prevent autoimmunity. Immunotherapy (2011) 0.87
Activating and inhibitory Fcgamma receptors can differentially modulate T cell-mediated autoimmunity. Eur J Immunol (2008) 0.87
Tolerogenic dendritic cells as a therapy for treating lupus. Clin Immunol (2013) 0.86
Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells. Eur J Immunol (2013) 0.86
Impaired learning resulting from respiratory syncytial virus infection. Proc Natl Acad Sci U S A (2013) 0.86
T-cell antagonism by short half-life pMHC ligands can be mediated by an efficient trapping of T-cell polarization toward the APC. Proc Natl Acad Sci U S A (2009) 0.85
Epidemic Clostridium difficile ribotype 027 in Chile. Emerg Infect Dis (2012) 0.85
Modulation of immunological synapse by membrane-bound and soluble ligands. Cytokine Growth Factor Rev (2007) 0.85
Deletion of a prophage-like element causes attenuation of Salmonella enterica serovar Enteritidis and promotes protective immunity. Vaccine (2010) 0.84
FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival. J Immunol (2012) 0.84
Interplay between behavioural thermoregulation and immune response in mealworms. J Insect Physiol (2012) 0.84
11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension. Endocrine (2009) 0.84
Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis. PLoS One (2012) 0.84
Salmonella pathogenicity island 1 differentially modulates bacterial entry to dendritic and non-phagocytic cells. Immunology (2010) 0.83
Use of genetically modified bacteria to modulate adaptive immunity. Curr Gene Ther (2009) 0.83